Login Register Cart 0
Generic placeholder image

Anti-Cancer Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5206
ISSN (Online): 1875-5992

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

New neo-Clerodane Diterpenoids Isolated from Ajuga decumbens Thunb., Planted at Pingtan Island of Fujian Province with the Potent Anticancer Activity

Author(s): Olagoke Zacchaeus Olatunde, Jianping Yong* and Canzhong Lu*

Volume 23, Issue 2, 2023

Published on: 26 August, 2022

Page: [237 - 244] Pages: 8

DOI: 10.2174/1871520622666220620151225

Price: $65

Abstract

Aims: The aim of this study is to find the anticancer lead compounds or drug candidates from Chinese Traditional Plant Medicine of Ajuga decumbens Thunb.

Background: Ajuga decumbens Thunb. has been used in clinical for a long time in China and was selected in “Chinses Pharmacopoeia” (part I in 1977) for its wide spectrum biological activities: such as anticancer, antioxidant, antifeedant, antibacterial, anti-inflammatory, antihyperlipidemic, anti-cholinesterase and cytotoxicity activities. However, there are relatively fewer studies of Ajuga decumbens Thunb. that have been carried out till now. For some years, our research group focused on the discovery of new anticancer agents, so we studied the chemical compositions of Ajuga decumbens Thunb., planted in Pingtan island of Fujian Province, to discover new anticancer lead compounds or candidates from this Chinese Traditional Plant Medicine.

Methods: The dichloromethane (DCM) extract was obtained in this work, and then this extract was used for silica gel column chromatography to obtain different polar fractions. Several similar fractions were combined according to TLC or HPLC analysis. The combined fractions were isolated by preparative TLC or preparative HPLC to obtain the pure compounds and HPLC was used to detect the purity. All isolated compounds were determined by NMR (1HNMR, 13CNMR, DEPT, HMBC, HSQC, 1H-1H COSY and NOESY), HRESIMS and single crystal X-ray diffraction methods. The in vitro anticancer activity was evaluated using CCK8 method.

Results: Seven compounds [three new compounds 1-3 ; and four known compounds (Ajugacumbins A, Ajugacumbin B, Ajugamarin A2 and Ajugamarin A1)] were isolated from Ajuga decumbens Thunb. in this work, and their structures were confirmed. The biological evaluation showed that 3 and Ajugamarin A1 exhibited potent in vitro anticancer activity both against A549 cell lines with IC50s=71.4 μM and 76.7 μM; and against Hela cell lines with IC50s=71.6 mM and 5.39×10-7 μM, respectively.

Conclusion: Compounds (3 and Ajugamarin A1) can be regarded as the lead compounds for the development of anticancer agents.

Keywords: Ajuga decumbens Thumb., neo-Clerodane diterpenoids, isolation, structural confirmation, NMR, single crystal X-ray diffraction, anticancer activity.

« Previous
Graphical Abstract

[1]
Cancer Research UK 2019. Available from: https://www.cancerresearchuk.org/about-cancer/what-is-cancer
[2]
Sarker, S.D.; Nahar, L.; Miron, A.; Guo, M.Q. Anticancer natural products. Annu. Rep. Med. Chem., 2020, 55, 45-75.
[http://dx.doi.org/10.1016/bs.armc.2020.02.001]
[3]
Gezici, S. Şekeroğlu, N. Current perspectives in the application of medicinal plants against cancer: Novel therapeutic agents. Anticancer. Agents Med. Chem., 2019, 19(1), 101-111.
[http://dx.doi.org/10.2174/1871520619666181224121004] [PMID: 30582485]
[4]
Seca, A.M.L.; Pinto, D.C.G.A. Plant secondary metabolites as anticancer agents: Successes in clinical trials and therapeutic application. Int. J. Mol. Sci., 2018, 19(1), 263.
[http://dx.doi.org/10.3390/ijms19010263] [PMID: 29337925]
[5]
Nahar, L.; Sarker, S.D. Chemistry for Pharmacy Students, 2nd ed; Wiley and Sons: Chichester, 2019.
[6]
Guo, P.; Li, Y.; Xu, J.; Liu, C.; Ma, Y.; Guo, Y. Bioactive neo-clerodane diterpenoids from the whole plants of Ajuga ciliata Bunge. J. Nat. Prod., 2011, 74(7), 1575-1583.
[http://dx.doi.org/10.1021/np2001557] [PMID: 21682262]
[7]
Coll, J.; Tandron, Y.A. neo-Clerodane diterpenoids from Ajuga: Structural elucidation and biological activity. Phytochem. Rev., 2008, 7(1), 25-49.
[http://dx.doi.org/10.1007/s11101-006-9023-3]
[8]
Xiong, Y.; Qu, W.; Sun, J.B.; Wang, M.T.; Liang, J.Y. Eudes-mane sesquiterpenoid lactones and abietane diterpenoids from Ajuga forrestii Diels. Phytochem. Lett., 2013, 6(3), 457-460.
[http://dx.doi.org/10.1016/j.phytol.2013.05.017]
[9]
Coll, J.; Tandrón, Y.A.; Zeng, X. New phytoecdysteroids from cultured plants of Ajuga nipponensis Makino. Steroids, 2007, 72(3), 270-277.
[http://dx.doi.org/10.1016/j.steroids.2006.11.017] [PMID: 17210166]
[10]
Castro, A.; Coll, J.; Tandrón, Y.A.; Pant, A.K.; Mathela, C.S. Phytoecdysteroids from Ajuga macrosperma var. breviflora roots. J. Nat. Prod., 2008, 71(7), 1294-1296.
[http://dx.doi.org/10.1021/np800131f] [PMID: 18529078]
[11]
Hussain, J.; Begum, N.; Hussain, H.; Khan, F.U.; Rehman, N.U.; Al-Harrasi, A.; Ali, L. Ajuganane: A new phenolic com-pound from Ajuga bracteosa. Nat. Prod. Commun., 2012, 7(5), 615-616.
[http://dx.doi.org/10.1177/1934578X1200700518] [PMID: 22799090]
[12]
Manguro, L.O.A.; Lemmen, P.; Hao, P. Iridoid glycosides from underground parts of Ajuga remota. Rec. Nat. Prod., 2011, 5, 147-157.
[13]
Kuria, K.A.M.; Chepkwony, H.; Govaerts, C.; Roets, E.; Bus-son, R.; De Witte, P.; Zupko, I.; Hoornaert, G.; Quirynen, L.; Maes, L.; Janssens, L.; Hoogmartens, J.; Laekeman, G. The antiplasmodial activity of isolates from Ajuga remota. J. Nat. Prod., 2002, 65(5), 789-793.
[http://dx.doi.org/10.1021/np0104626] [PMID: 12027771]
[14]
Nanjing University of Chinese Medicine. Dictionary of Chi-nese Materia Medica, 2nd ed; Shanghai Science and Technol-ogy Publishing House: Shanghai, 2006, pp. 1035-1037.
[15]
Min, Z.D.; Wang, S.Q.; Zheng, Q.T.; Wu, B.; Mizuno, M.; Tanaka, T.; Iinuma, M. Four new insect antifeedant neo-clerodane diterpenoids, ajugacumbins A, B, C, and D, from Ajuga decumbens. Chem. Pharm. Bull. (Tokyo), 1989, 37(9), 2505-2508.
[http://dx.doi.org/10.1248/cpb.37.2505]
[16]
Chen, H.; Tang, B.Q.; Chen, L.; Liang, J.Y.; Sun, J.B. Neo-clerodane diterpenes and phytoecdysteroids from Ajuga de-cumbens Thunb. and evaluation of their effects on cytotoxic, superoxide anion generation and elastase release in vitro. Fitoterapia, 2018, 129, 7-12.
[http://dx.doi.org/10.1016/j.fitote.2018.06.004] [PMID: 29894737]
[17]
Cai, X.M.; Liu, Y.; Mu, B.; Zeng, M.; Yang, J.B.; Shen, Y.W.; Chen, B.F.; Liang, S.H. Study on antihyperlipidemic effect of Ajuga Decumbens Thunb. original extract. China Pharmaceu-ticals, 2012, 21(15), 7-8.
[18]
Zhang, B.; Zeng, F.J.; Zhang, X.Y. Study on anti-infection effect of Ajuga. Zhongguo Yiyuan Ganranxue Zazhi, 2014, 24(12), 2937-2939.
[19]
Xu, Y.; Fang, J.; Yu, C.H.; Ye, H.C. Inhibition of fractions and compounds from Ajuga decumbens on acetylcholinester-ase activity. Zhonghua Zhongyiyao Xuekan, 2013, 31(3), 565-566.
[20]
Wang, J.J.; Peng, B.; He, R.; Xu, Q.H.; Han, J.Y.; Li, J.R. Pre-liminary research on effect of combination of Ajuga decum-bens and Poria cocos on invasion and metastasis of breast cancer. Zhongguo Yaolixue Tongbao, 2017, 33(4), 581-588.
[21]
Peng, B.; He, R.; Xu, Q.; Gao, J.; Lu, Y.; Li, J. Correlation between antimetastatic action of Ajuga decumbens and ex-pression of MMPs and TIMPs. Zhongguo Zhongyao Zazhi, 2011, 36(24), 3511-3514.
[PMID: 22368868]
[22]
Zeng, M.G.; Jia, R.; Wu, F.H. Experiment of tumor inhibition of Ciliate Bugle Herb in S180 sarcom mice. J. Fujian College of TCM, 2003, 13(2), 30-31.
[23]
Peng, B.; He, R.; Han, J.Y.; Yang, Y.F.; Xu, Q.H.; Li, J.R. Intervention effect of Ajuga decumbens Iridoids on character-istics of breast cancer stem cells via ERK MAPK and PI3K/Akt signaling pathways. Zhongguo Shiyan Fangjixue Zazhi, 2017, 23(18), 94-99.
[24]
Tominaga, H.; Ishiyama, M.; Ohseto, F.; Sasamoto, K.; Hamamoto, T.; Suzuki, K.; Watanabe, M.A. Water-soluble te-trazolium salt useful for colorimetric cell viability assay. Anal. Commun., 1999, 36(2), 47-50.
[http://dx.doi.org/10.1039/a809656b]
[25]
Yang, Y.; Yong, J.P.; Olatunde, O.Z.; Lu, C.Z. Chemical com-ponents isolated from the leaves of Podocarpus nagi planted in Fujian and preliminary in vitro anticancer activity. Acad. J. Med. Plants., 2021, 9(2), 19-22.
[26]
Xiao, Y.C.; Yong, J.P.; Yang, Y.; Lu, C.Z. The ethyl acetate extraction obtained from Podocarpus Nagi kernel Meal with anticancer activity. Biomed. Pharmacol. J., 2021, 14(1), 363-366.
[http://dx.doi.org/10.13005/bpj/2134]
[27]
Coll, J. NMR shift data of neo-clerodane diterpenes from the genus Ajuga. Phytochem. Anal., 2002, 13(6), 372-380.
[http://dx.doi.org/10.1002/pca.671] [PMID: 12494759]
[28]
Yong, J.; Lu, C.; Wu, X. Synthesis of isoxazole moiety con-taining thieno[2,3-d]-yrimidine derivatives and preliminarily in vitro anticancer activity (Part II). Anticancer. Agents Med. Chem., 2015, 15(9), 1148-1155.
[http://dx.doi.org/10.2174/1871520615666150305103122] [PMID: 25742095]
[29]
Yong, J.; Lu, C.; Wu, X. Synthesis and biological evaluation of quinazoline derivatives as potential anticancer agents (II). Anticancer. Agents Med. Chem., 2015, 15(10), 1326-1332.
[http://dx.doi.org/10.2174/1871520615666150526115904] [PMID: 26008189]
[30]
Yong, J.P.; Lu, C.Z.; Wu, X. Potential anticancer agents. I. Synthesis of isoxazole moiety containing quinazoline deriva-tives and preliminarily in vitro anticancer activity. Anticancer. Agents Med. Chem., 2015, 15(1), 131-136.
[http://dx.doi.org/10.2174/1871520614666140812105445] [PMID: 25142319]
[31]
Lu, C.Z.; Yong, J.P. Quinazoline derivatives and application thereof. U. S. patent 9,193,718B2, 2015.
[32]
Yong, J.P.; Lu, C.Z. Ferrocene drivatives, preparation method and use thereof. U. S. patent 9,738,673B1 2017.
[33]
Lu, C. Z.; Yong, J. P. Thieno[2,3-d]Pyrimidine derivatives, preparation method and use Thereof. U. S patent 9,434,741B2, 2016.

Rights & Permissions Print Cite
Article Metrics
31
3
© 2024 Bentham Science Publishers | Privacy Policy